中国药物警戒 ›› 2014, Vol. 11 ›› Issue (9): 554-556.

• 药械安全性研究 • 上一篇    下一篇

儿童退热类化学药安全性问题的相关研究

杨月明1,田春华2魏晶1金丹1马辉11王瑜歆1王立刚1杨华1耿凤英1   

  1. 1辽宁省药品不良反应监测中心, 辽宁沈阳110003;
    2国家食品药品监督管理局药品评价中心, 北京100045)
  • 收稿日期:2013-11-12 修回日期:2016-02-03 出版日期:2014-09-08 发布日期:2016-03-02
  • 作者简介:杨月明, 女, 主管药师, 药品不良反应监测。

YANG Yue-ming1 TIAN Chun-hua2 WEI Jing1 JIN Dan1 MA Hui1 WANG Yu-xin1 WANG Li-gang1 YANG Hua1 GENG Feng-ying1 (1Liaoning Adverse Drug Reaction Monitoring Center, Liaoning Shenyang 110003, China;

  1. 2Center for Drug Reevaluation, CFDA, Beijing100045, China
  • Received:2013-11-12 Revised:2016-02-03 Online:2014-09-08 Published:2016-03-02

摘要: 通过采用回顾性分析方法,分别对乙酰氨基酚、布洛芬、安痛定、安乃近、赖氨匹林不良反应进行文献分析。运用比较研究法,介绍美国FDA和欧盟EMA用药指南、风险管理策略及风险干预措施,对比国内外对乙酰氨基酚和布洛芬的儿科说明书情况,对我国儿童用退热药管理中存在的问题进行汇总分析,进而为儿童退热类化学药品的合理使用提供建议和参考。

关键词: 儿童退热类化学药, 不良反应, 用药指南, 风险管理策略, 风险干预措施

Abstract: The retrospective study was used to review the adverse drug reaction of paracetamol, ibuprofen, alidine, analgin and aspirin-DL-lysine. Using method of comparative study, we introduced the medication guide, risk management strategy and risk intervention measures of FDA and EMA.Comparing pediatric labeling of paracetamol and ibuprofen between China and the U.S. This paper analyzed the reasons of problems existing in different aspects of pediatric antipyretic administration and gave proposals for its use.

Key words: antipyretics for children, adverse drug reaction, medication guide, risk management strategy, risk intervention measures

中图分类号: